3 ms·
What I don't get is why the EU doesn't buy the vaccine patents from e.g. Pfizer (or failing that, buy Pfizer outright - it would still only cost a fraction of w
by m12k 6y ago
What I don't get is why the EU doesn't buy the vaccine patents from e.g. Pfizer (or failing that, buy Pfizer outright - it would still only cost a fraction of what the lockdowns and aid packages have cost) and release the patents into public domain, so all companies with the capability can produce the vaccine. If it could hasten the reopenings by just one month, it would still be a terrific ROI.
- _ph_ 6y agoBecause there are no companies around which can produce mRNA vaccine. The production process is very specific. Opening up the patents wouldn't help. There are cooperations with those production steps which are generic, like botteling of the vaccines. Fortunately, another factory for BioNTech (which are the people who are making the vaccine, Pfizer is just the large partner) opened up in Germany recently and is going to produce a significant amount of doses. But instead of 1 more like 10 of these factories should have been built.